Skip to content

Home
About Us
- Team
- Job Openings
Antivirals
- BK Virus
Immuno-Oncology
Pledge AI
News & Presentations
- News
- Presentations

Home
About Us
- Team
- Job Openings
Antivirals
- BK Virus
Immuno-Oncology
Pledge AI
News & Presentations
- News
- Presentations

Orthogon Therapeutics Announces an $8m Follow-On Financing to Advance Its Lead BK Virus Drug

By November 10, 2025

NextFormer Novartis Executive Dr. Marie Lindner Joins Orthogon Therapeutics’ Board of DirectorsNext

Our discovery platform can tailor novel and clinically relevant compounds for some of the most exciting targets that remain out of therapeutic reach.

CAREERS

Are you a passionate and driven professional seeking a new opportunity? See our recent job openings.

NORTH AMERICA

45 Dan Rd., Ste. 382
Canton, MA 02021
USA

+1 339-502-8643

info@pledge-tx.com

EUROPE

Gaston Geenslaan 1
3001 Leuven
Belgium

+32 16 85 26 80

info@pledge-tx.com

Linkedin Twitter

© 2026 Pledge Therapeutics. All rights reserved

Biotech Website Design

Home
About Us
- Team
- Job Openings
Antivirals
- BK Virus
Immuno-Oncology
Pledge AI
News & Presentations
- News
- Presentations

Home
About Us
- Team
- Job Openings
Antivirals
- BK Virus
Immuno-Oncology
Pledge AI
News & Presentations
- News
- Presentations

Linkedin Twitter